Items where authors include "McNeill, M."

Article

Miller, T.M., Cudkowicz, M.E., Shaw, P.J. et al. (428 more authors) (2025) Long-term tofersen in SOD1 amyotrophic lateral sclerosis. JAMA Neurology. ISSN 2168-6149

Miller, T.M., Cudkowicz, M.E., Genge, A. et al. (23 more authors) (2022) Trial of antisense oligonucleotide tofersen for SOD1 ALS. New England Journal of Medicine, 387 (12). pp. 1099-1110. ISSN 0028-4793

Shaw, P. orcid.org/0000-0002-8925-2567, Miller, T., Cudkowicz, M. et al. (7 more authors) (2022) Tofersen in adults with SOD1-ALS: phase 3 VALOR trial and open-label extension results. Journal of Neurology, Neurosurgery & Psychiatry, 93 (9). e2. ISSN 0022-3050

Miller, T., Cudkowicz, M., Shaw, P.J. orcid.org/0000-0002-8925-2567 et al. (28 more authors) (2020) Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. New England Journal of Medicine, 383 (2). pp. 109-119. ISSN 0028-4793

Proceedings Paper

Miller, T.M., Cudkowicz, M.E., Shaw, P.J. orcid.org/0000-0002-8925-2567 et al. (9 more authors) (2025) Final results from the phase 3 VALOR trial and open-label extension evaluating efficacy and safety of tofersen in adults with SOD1-ALS. In: Muscle & Nerve. 24th Annual Meeting of the Northeast ALS Consortium, 07-10 Oct 2025, Florida, USA. , S97-S97.